Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus placebo for osteoarthritis knee pain
2006-003485-33Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of duloxetine in knee osteoarthritis (OA) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Weekly mean of 24-hour average pain scores. Started Nov 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-003485-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003485-33.